The FDA says it received over 200 reports associated with Penumbra’s catheter, including ‘deaths, serious injuries, and malfunctions.’ Penumbra (PEN) shares slumped Wednesday after the medical device ...
Penumbra has issued an urgent recall of all configurations of the Penumbra JET 7 Reperfusion Catheter With Xtra Flex Technology (JET 7 Xtra Flex), owing to the risk for "unexpected death or serious ...
Now available in the U.S., RED ™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...
Penumbra has been impacted by the pandemic and the recall of its leading-edge neurovascular aspiration catheter, but those only look like bumps in the growth story. With the JET 7 Flex Xtra off the ...
Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest ...
Clinical Experience with Penumbra JET™ 7 Reperfusion Catheter with XTRA FLEX Technology to be Highlighted at Company-Sponsored Symposium MIAMI--(BUSINESS WIRE)-- Penumbra, Inc. (NYSE: PEN), a global ...
Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results